First Test That Can Detect COVID-19 Virus Mutations Authorized By FDA

The US FDA on 10 June authorized use of Illumina’s COVIDSeq next generation sequencing diagnostic test to detect the SARS-CoV-2 virus and figure out if it’s mutating. The agency has high hopes this first-of-its-kind test will give researchers a better picture in the ongoing global fight against the COVID-19 pandemic.

Virus and mutations process 3d illustartion. New virus mutation of coronavirus, hantavirus, COVID-19, pandemic concept background for health, medical design. Coronavirus mutation 3d rendering.
The FDA is optimistic Illumina’s COVIDSeq NGS test can help researchers understand potential mutations of the SARS-COV-2 virus, as illustrated

More from Business

More from Medtech Insight